6:29 PM
Oct 01, 2012
 |  BC Extra  |  Company News

Takeda, Lundbeck seek FDA review of depression therapy

H. Lundbeck A/S (CSE:LUN) and partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502)...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >